Immediate Impact

49 standout
Sub-graph 1 of 23

Citing Papers

Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Global, regional, national epidemiology and trends of Parkinson’s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021
2025 Standout
3 intermediate papers

Works of Jonathan Calkwood being referenced

DOP45 Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis
2022
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
2015
and 1 more

Author Peers

Author Last Decade Papers Cites
Jonathan Calkwood 302 130 89 141 14 404
Livianna Speciale 121 55 42 57 18 450
Stefania Tamiazzo 54 102 60 130 13 384
H. J. Nordal 127 118 54 38 16 425
Nikki van Driel 150 53 50 40 15 356
Aggrey Nyongo 163 30 219 95 16 387
Kristina Kakalacheva 177 45 97 51 10 348
Hang Liu 83 43 44 83 17 408
Jiehao Zhou 68 26 63 79 14 427
Polina Sonis 266 161 59 312 13 432
Albert Quiery 69 27 115 145 13 399

All Works

Loading papers...

Rankless by CCL
2026